Clincosm LogoSign in Get a demo

Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study

Sponsor
University Medical Center Groningen (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05395559
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (Other), Health∼Holland, Topsector Life Sciences & Health (Other)
1,200
Enrollment

Study Details

Study Description

Brief Summary

The aim of this multicenter, cross-sectional, observational flash mob study is to investigate the prevalence of cognitive impairment in hospitalized elderly aged 65 years or older, and the recognition of cognitive impairment by healthcare professionals.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1200 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
    Anticipated Study Start Date :
    Sep 21, 2022
    Anticipated Primary Completion Date :
    Sep 21, 2022
    Anticipated Study Completion Date :
    Sep 21, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Percentage of hospitalized patients aged 65 years or older with cognitive impairment [Baseline]

      Cognitive impairment is measured with the Mini-Cog

    2. Percentage of hospitalized patients aged 65 years or older with cognitive impairment that has been recognized by nurses, physicians, both their nurse and physician, and either their nurse or physician [Baseline]

      Cognitive impairment is measured with the Mini-Cog

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Dutch-speaking

    • Hospitalized

    • Age ≥ 65 years old

    Exclusion Criteria:

    • Unable to perform the Mini-Cog (e.g. due to visual impairment, severe hearing loss, being too ill, or otherwise unable to speak or write)

    • Patients who require medical isolation

    • Not willing to participate.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University Medical Center Groningen
    • ZonMw: The Netherlands Organisation for Health Research and Development
    • Health∼Holland, Topsector Life Sciences & Health

    Investigators

    • Principal Investigator: Barbara C van Munster, Prof. dr., University Medical Center Groningen, University Center for Geriatric Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Medical Center Groningen
    ClinicalTrials.gov Identifier:
    NCT05395559
    Other Study ID Numbers:
    • 202200087
    First Posted:
    May 27, 2022
    Last Update Posted:
    Aug 17, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Medical Center Groningen
    Elderly
    Hospitalization
    Additional relevant MeSH terms:
    Alzheimer Disease
    Delirium
    Cognitive Dysfunction

    Study Results

    No Results Posted as of Aug 17, 2022